Source: Zacks

Smith & Nephew: SNN Stock Might Rise Following FDA Nod for AETOS Stemless

Smith & Nephew received FDA 510(k) clearance for a stemless anatomic total shoulder, AETOS Stemless. This represents a significant advancement in shoulder arthroplasty.

Read full article »
Annual Revenue
$5.0-10B
Employees
10-50K
Deepak Nath's photo - CEO of Smith & Nephew

CEO

Deepak Nath

CEO Approval Rating

68/100

Read more